4//SEC Filing
Biotest AG 4
Accession 0001193805-17-003457
CIK 0001368514other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 1:54 PM ET
Size
7.1 KB
Accession
0001193805-17-003457
Insider Transaction Report
Form 4
Biotest AG
Director10% Owner
Transactions
- Purchase
Common Stock
2017-11-09$2.15/sh+5,813,954$12,500,001→ 10,109,534 total(indirect: By Biotest Pharmaceuticals Corporation)
Biotest Pharmaceuticals Corp
Director10% Owner
Transactions
- Purchase
Common Stock
2017-11-09$2.15/sh+5,813,954$12,500,001→ 10,109,534 total(indirect: By Biotest Pharmaceuticals Corporation)
Footnotes (2)
- [F1]Represents a purchase from the underwriters in the issuer's public offering.
- [F2]The shares are owned directly by Biotest Pharmaceuticals Corporation, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG. Biotest AG is a director and a ten percent owner of the issuer.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
IncorporatedGermany
Related Parties
1- filerCIK 0001709152
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 1:54 PM ET
- Size
- 7.1 KB